(Q39863380)

English

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.

scientific article published on 16 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

object named as

Beom Kyung Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Do Young Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ja Kyung Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Do Youn Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kwang Hoon Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

659-667

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

https://scigraph.springernature.com/pub.10.1007/s00432-010-0917-5

0 references

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uraci

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Diagnosis and Treatment of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0917-5

21 January 2018

Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN clinical practice guidelines in oncology: hepatobiliary cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Practice guideline for diagnosis and treatment of hepatocellular carcinoma].

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20552225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-010-0917-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

release_5g35igimfjg4vorxm64qlpncli

1 reference

https://api.fatcat.wiki/v0/release/5g35igimfjg4vorxm64qlpncli

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20552225%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39863380&oldid=2106817182"